HealthCare Royalty

HealthCare Royalty, also known as HCRx, is a leading royalty acquisition company headquartered in Stamford, Connecticut. The company employs 33 individuals, including a team of seasoned professionals with diverse backgrounds in pharmaceuticals, biotechnology, and finance. HealthCare Royalty's focus is on acquiring royalty rights for commercial or near-commercial stage biopharmaceutical products. HCRx invests in healthcare assets with strong clinical value and significant barriers to entry, targeting products that offer sustainable long-term revenue streams. They operate across the pharmaceutical, biotechnology, and specialty pharmaceuticals sectors. Their investment portfolio comprises over 85 biopharma products, with a total investment exceeding $5 billion since the company's inception. HealthCare Royalty distinguishes itself through its flexible investment platform designed to act as a long-term capital resource for its partners. They utilize various investment approaches, including customized debt, royalty monetization, and revenue participation financings, tailored to meet the specific needs and objectives of their partners. The HCRx team brings extensive experience, having completed over 60 healthcare investments since 2003. For inquiries or further information, please visit HealthCare Royalty's website at hcrx.com.